Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai

Recruiting now

Conditions studied: Breast Cancer Awareness

In brief

Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with mammography and, when available, biopsy to assess sensitivity and negative predictive value. Feminai is investigational, intended to support clinical decision-making, and does not replace standard diagnostic tests.

Key facts

Study ID
NCT07220863
Run by
Feminai
People needed
300
Starts
2025-10-05
Expected to finish
2026-09-05
Last updated by the study team
2025-10-24

Who can join

Age: 25 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.